Literature DB >> 17195038

[Cutaneous B-cell lymphoma. Classification and diagnostics].

E Geissinger1, P Adam, H K Müller-Hermelink, T Rüdiger.   

Abstract

Primary cutaneous B-cell lymphomas include cutaneous follicle centre lymphoma (PCFCL), cutaneous marginal zone B-cell lymphoma (PCMZL) and cutaneous diffuse large B-cell lymphoma (PCLBCL) "leg type" which are the three main types in the new WHO-EORTC classification for cutaneous lymphomas. PCFCL and PCMZL are indolent lymphomas with an excellent prognosis while PCLBCL shows an aggressive clinical course. All three types must be distinguished from a secondary skin involvement by systemic lymphomas. Since histological and immunohistochemical findings are not decisive, making this distinction requires appropriate staging procedures. In contrast, the pathologist can make an important contribution to the differential diagnosis between neoplastic and reactive cutaneous lymphoproliferations.

Entities:  

Mesh:

Year:  2007        PMID: 17195038     DOI: 10.1007/s00292-006-0881-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  18 in total

1.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.

Authors:  Juliette J Hoefnagel; Remco Dijkman; Katia Basso; Patty M Jansen; Christian Hallermann; Rein Willemze; Cornelis P Tensen; Maarten H Vermeer
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

Review 2.  Primary cutaneous B-cell lymphoma: classification and treatment.

Authors:  Rein Willemze
Journal:  Curr Opin Oncol       Date:  2006-09       Impact factor: 3.645

3.  Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.

Authors:  I Mirza; N Macpherson; S Paproski; R D Gascoyne; B Yang; W G Finn; E D Hsi
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.

Authors:  G S Wood; N V Kamath; J Guitart; P Heald; S Kohler; B R Smoller; L Cerroni
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

5.  Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.

Authors:  Remco Dijkman; Cornelis P Tensen; Ekaterina S Jordanova; Jeroen Knijnenburg; Juliette J Hoefnagel; Aat A Mulder; Carla Rosenberg; Anton K Raap; Rein Willemze; Károly Szuhai; Maarten H Vermeer
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

6.  Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.

Authors:  J R Goodlad; M M Davidson; K Hollowood; C Ling; C MacKenzie; I Christie; P J Batstone; D O Ho-Yen
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

7.  Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.

Authors:  F Grange; M W Bekkenk; J Wechsler; C J Meijer; L Cerroni; M Bernengo; J Bosq; G Hedelin; R Fink Puches; W A van Vloten; P Joly; M Bagot; R Willemze
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

8.  Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.

Authors:  Kazuo Kodama; Cesare Massone; Andreas Chott; Dieter Metze; Helmut Kerl; Lorenzo Cerroni
Journal:  Blood       Date:  2005-06-09       Impact factor: 22.113

9.  Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.

Authors:  O P Sangueza; S Yadav; C R White; R M Braziel
Journal:  Am J Dermatopathol       Date:  1992-10       Impact factor: 1.533

10.  Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.

Authors:  Kirsten Grønbaek; Elisabeth Ralfkiaer; Jörg Kalla; Gunhild L Skovgaard; Per Guldberg
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

View more
  1 in total

Review 1.  [Treatment of indolent cutaneous B‑cell lymphoma].

Authors:  M Wobser
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.